OSR Health seeks sale of controlling OSRK stake to Nasdaq-listed buyer
OSRH•OSR Health's board authorized management to pursue exchanging its approximately 84.5% stake in OSRK for shares in an undisclosed Nasdaq-listed buyer. The proposed transaction would make OSR Health the buyer's controlling shareholder, with the combined company owning all of OSRK; total value, including a proposed earn-out, would exceed the valuation used for OSRK's February 2025 acquisition.
1. Proposed stake exchange
OSR Health's board authorized management to pursue a transaction with an undisclosed Nasdaq-listed counterparty, exchanging its approximately 84.5% interest in OSRK for shares in the buyer. OSR Health would become the buyer's controlling shareholder, and the combined company would own 100% of OSRK. Total transaction value, including a proposed earn-out, would exceed the valuation used for OSRK's acquisition in February 2025.
